Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial

Gespeichert in:
Bibliographische Detailangaben
Weitere Verfasser: Breithardt, Günter (BerichterstatterIn) , Hacke, Werner (BerichterstatterIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2014
In: European heart journal
Year: 2014, Jahrgang: 35, Heft: 47, Pages: 3377-85
ISSN:1522-9645
DOI:10.1093/eurheartj/ehu305
Online-Zugang:Verlag, kostenfrei, Volltext: http://eurheartj.oxfordjournals.org/content/ehj/35/47/3377.full.pdf
Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1093/eurheartj/ehu305
Volltext
Verfasserangaben:Günter Breithardt ... Werner Hacke...

MARC

LEADER 00000caa a2200000 c 4500
001 1495988961
003 DE-627
005 20220811181606.0
007 cr uuu---uuuuu
008 150206s2014 xx |||||o 00| ||eng c
024 7 |a 10.1093/eurheartj/ehu305  |2 doi 
035 |a (DE-627)1495988961 
035 |a (DE-576)425988961 
035 |a (DE-599)BSZ425988961 
035 |a (OCoLC)1340659940 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
084 |a 33  |2 sdnb 
245 0 0 |a Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial  |c Günter Breithardt ... Werner Hacke... 
264 1 |c 2014 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am: 06.02.2015 
700 1 |a Breithardt, Günter  |d 1944-  |0 (DE-588)171989201  |0 (DE-627)672867559  |0 (DE-576)132865599  |4 oth 
700 1 |a Hacke, Werner  |d 1948-  |0 (DE-588)12021699X  |0 (DE-627)080530346  |0 (DE-576)164358854  |4 oth 
773 0 8 |i In  |t European heart journal  |d Oxford : Oxford University Press, 1980  |g 35(2014), 47, Seite 3377-85  |h Online-Ressource  |w (DE-627)320415813  |w (DE-600)2001908-7  |w (DE-576)103746846  |x 1522-9645  |7 nnas  |a Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial 
773 1 8 |g volume:35  |g year:2014  |g number:47  |g pages:3377-85  |g extent:9  |a Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial 
856 4 0 |u http://eurheartj.oxfordjournals.org/content/ehj/35/47/3377.full.pdf  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u http://dx.doi.org/10.1093/eurheartj/ehu305  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20150206 
993 |a Article 
994 |a 2014 
998 |g 12021699X  |a Hacke, Werner  |m 12021699X:Hacke, Werner  |d 910000  |d 911100  |e 910000PH12021699X  |e 911100PH12021699X  |k 0/910000/  |k 1/910000/911100/  |p 12 
999 |a KXP-PPN1495988961  |e 2832390900 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1495988961","physDesc":[{"extent":"9 S."}],"language":["eng"],"id":{"doi":["10.1093/eurheartj/ehu305"],"eki":["1495988961"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title":"Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial","title_sort":"Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial"}],"person":[{"given":"Günter","role":"oth","family":"Breithardt","display":"Breithardt, Günter"},{"role":"oth","given":"Werner","family":"Hacke","display":"Hacke, Werner"}],"note":["Gesehen am: 06.02.2015"],"origin":[{"dateIssuedDisp":"2014","dateIssuedKey":"2014"}],"relHost":[{"pubHistory":["1.1980 -"],"disp":"Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trialEuropean heart journal","recId":"320415813","origin":[{"publisher":"Oxford University Press ; Harcourt","dateIssuedDisp":"1980-","dateIssuedKey":"1980","publisherPlace":"Oxford ; London [u.a.]"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2001908-7"],"issn":["1522-9645"],"eki":["320415813"]},"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"title_sort":"European heart journal","title":"European heart journal"}],"part":{"extent":"9","issue":"47","text":"35(2014), 47, Seite 3377-85","year":"2014","pages":"3377-85","volume":"35"},"note":["Gesehen am 12.09.2017"]}],"name":{"displayForm":["Günter Breithardt ... Werner Hacke..."]}} 
SRT |a CLINICALCH2014